MeSH tree: C16.131.240.850
Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects ...
Sep 9, 2026
0
7
Blood flows around the body through a complex network of vessels, which must constantly adapt to changing needs. The balance between growing new vessels and stabilizing existing vessels, so they aren't leaky, must be finely ...
Feb 5, 2026
0
16
Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting one in 3,800 persons. HHT's hallmark symptom is chronic nosebleeds, which often occur alongside other ...
Nov 26, 2025
0
24
The cost of emergency dialysis is estimated to be eight times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, Texas) resulted in a significant decrease ...
Nov 8, 2025
0
17
To undergo kidney dialysis, doctors must first surgically create an access route—an arteriovenous fistula—usually in an arm, a conduit that will accommodate hemodialysis treatments. It is a routine outpatient procedure performed ...
More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney transplant. To prepare for ...
Sep 24, 2025
0
16
System-based disparities in predialysis access to nephrology care contribute to disparities in the likelihood of having a mature, usable arteriovenous access for starting hemodialysis (incident vascular access) among Hispanic ...
Sep 5, 2025
0
18
A Boston Children's Hospital study uncovers how fetal magnetic resonance imaging (MRI) could be a game-changer in predicting outcomes for infants born with vein of Galen malformations (VOGMs).
Apr 8, 2025
0
9
During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many intracellular pathways—series of signaling cascades within a cell—regulate these actions to avoid non-programmed ...
Mar 31, 2025
0
12
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than one in 5,000 people worldwide.
Sep 18, 2024
0
42
